Opinion: Two-year-old Pandemic, Less Answers

Thanks for tuning in!

As part of our off-season series, we discussed trending issues at home and abroad.

In this episode, we discussed the ongoing 2-year-old pandemic touching on some of the questions, narratives, science, and data that keep popping up. 

.

.

.

If you love listening to the podcast, here's how you can support us!

1. Leave us a review where you're listening right now! 💫
2. Follow us on Twitter (@yellowpill_pod) 🐦
3. Follow us on Instagram (@theyellowpillpod) 📷
4. Subscribe to The Yellow Pill Newsletter on Substack 🗞

.

.

.

References Used

1. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
   
   
2. What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant? : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554481/
   
   
3. Omicron-variant border bans ignore the evidence, say scientists : https://www.icpcovid.com/sites/default/files/2021-12/Ep%20197-4%20Omicron-variant%20border%20bans%20ignore%20the%20evidence%2C%20say%20scientists.pdf
   
   
4. Pfizer revenue and profits soar on its Covid vaccine business: https://edition.cnn.com/2021/11/02/business/pfizer-earnings/index.html
   
   
5. Monoclonal Antibodies for COVID-19: https://jamanetwork.com/journals/jama/fullarticle/2776307
   
   
6. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel: https://www.nejm.org/doi/full/10.1056/NEJMoa2109730
   
   
7. VAERS Summary for COVID-19 Vaccines through 11/19/2021: https://vaersanalysis.info/2021/12/01/vaers-summary-for-covid-19-vaccines-through-11-19-2021/
   
   
8. Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366801/
   
   
9. Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0237693
   
   
10. Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection: https://www.amjmed.com/article/S0002-9343(20)30673-2/pdf
    
    
11. Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework: https://journalotohns.biomedcentral.com/articles/10.1186/s40463-020-00474-x
    
    
12. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era: https://pubmed.ncbi.nlm.nih.gov/32520599/